JC

Jeremy Caldwell

Investor at Red Tree Investor

San Diego, California

Overview 

Jeremy Caldwell is a Partner at Red Tree Venture Capital in San Diego, California, with a PhD from Stanford University School of Medicine and a BA from University of California, Berkeley. He has held leadership roles at various biotechnology companies, including President and CEO at Inception Therapeutics and Mistral Therapeutics, and has served on the Board of Directors for companies like Lycia Therapeutics and Belharra Therapeutics. Caldwell's career highlights include leading successful biotechnology companies, such as Inception Therapeutics and Mistral Therapeutics, and serving on the Board of Directors for multiple prominent biotech firms, demonstrating his expertise in the industry and his ability to drive innovation and growth in the sector.

Work Experience 

ST

Sardona Therapeutics

  • Board Member

    2023 - Current

Sardona Therapeutics is a Scaling New Peaks in Cancer Therapy.

sardonatx.com
RT

Red Tree Venture Capital

  • Partner, Red Tree Venture Capital

    2023

BT

Belharra Therapeutics

  • Board of Directors

    2021 - 2023

Belharra Therapeutics disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform.

Raised $50,000,000.00 from Versant Ventures.

belharratx.com
VV

Versant Ventures

  • Venture Partner

    2018 - 2023

Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.

versantventures.com
IT

Inception Therapeutics

  • President and Chief Executive Officer

    2018 - 2023

LT

Lycia Therapeutics

  • Board of Directors

    2020 - 2021

Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.

Raised $226,600,000.00 from Blue Owl, Redmile Group, Alexandria Venture Investments, Invus, Marshall Wace, Franklin Templeton, Venrock Healthcare Capital Partners, RTW Investments, Eli Lilly and Cowen Healthcare Investments.

lyciatx.com
CT

Chinook Therapeutics, Inc.

  • Board of Directors

    2019 - 2020

Mistral Therapeutics

  • President and Chief Executive Officer

    2018 - 2018

AI

Ardelyx, Inc.

  • Executive Vice President and Chief Scientific Officer

    2014 - 2018

Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.

Raised $557,675,321.00 from Kyowa Kirin, HealthCare Royalty Partners and SLR Capital Partners.

ardelyx.com
TR

Third Rock Ventures

  • Entrepreneur in Residence

    2014 - 2014

Education 

Investments 

Lycia Therapeutics

Series B

Total funding: $70M

Articles About Jeremy

Relevant Websites